Enrique Herrera‐Ceballos

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

P. Dávila‐Seijo, E. Daudén, M.Á. Descalzo et al. · Journal of Investigative Dermatology · 2016 · 123 citations · Full text

Classic Systemic Drugs, Psoriatic Arthritis, Clinical Dermatology +6

Survival of classic and biological systemic drugs in psoriasis: results of the <scp>BIOBADADERM</scp> registry and critical analysis

P. Dávila‐Seijo, E. Daudén, G. Carretero et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 97 citations

UVA and UVB Photoprotective Capabilities of Topical Formulations Containing Mycosporine-like Amino Acids (MAAs) through Different Biological Effective Protection Factors (BEPFs)

Francisca de la Coba, José Aguilera, Nathalie Korbee et al. · Marine Drugs · 2019 · 93 citations · Full text

Dermatology, Commercial Sunscreens, Phototoxicity +16

Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

J.M. Carrascosa, M. Vilavella, I. García‐Doval et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 75 citations

Rational Design and Synthesis of Efficient Sunscreens To Boost the Solar Protection Factor

Raúl Losantos, Ignacio Funes‐Ardoiz, José Aguilera et al. · Angewandte Chemie International Edition · 2017 · 73 citations